Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aosen New Material is a specialized chemical manufacturer headquartered in Hebei, China, that provides essential raw materials and intermediates for the pharmaceutical and medical device industries. The company is a prominent producer of bio-based materials, including Isosorbide and Polycaprolactone (PCL), which are critical for the development of biodegradable medical implants and controlled-release drug formulations. Beyond its life science applications, Aosen manufactures a wide range of high-performance plasticizers and flame retardants used in various industrial sectors. The company operates advanced manufacturing facilities designed to meet high-purity standards required for chemical synthesis and material science. By serving as a reliable supplier of specialized polymers and intermediates, Aosen New Material supports the global healthcare supply chain and the advancement of sustainable material technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aosen New Material.